Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by coyote13on Dec 08, 2016 3:34pm
317 Views
Post# 25573500

RE:RE:RE:RE:Broker is in agreement...

RE:RE:RE:RE:Broker is in agreement...If you are right Staghorn and you may well be as it relates to the Analyst Day thinking and plan ( using the word thinking and plan in the context of PLI, loosely ), I think PL et al received bad advice if their plan was to make a major announcement at that time.

Better strategy is to halt the stock , release news and have a conf call. There ws no meat on the bones at AD and in fact given the number of references on the Q3 call to AD disclosure and then to leave us hanging may well have sent what little institutional support we have running for the exits.

Don't need to tell you what we are down post AD.

Coyote13





Bullboard Posts